Met-Enkephalin
Met-Enkephalin is an endogenous opioid peptide involved in several signalling processes. It is also known as opioid growth factor, or OGF, when discussed in relation to growth-regulatory pathways.
Low-dose OGF approaches have been explored in immune-regulation research. These approaches at MRC begin with physician consultation and complement evidence-based care.
What Is Met-Enkephalin?
Met-Enkephalin is a five-amino-acid peptide produced within the body. Its name reflects the methionine residue at one end of its sequence.
The same peptide can be discussed in different biological contexts. Classical opioid-receptor activity and OGF-receptor signalling are related to different proposed effects.
How Does Met-Enkephalin Work?
Met-Enkephalin can interact with opioid receptors and with the opioid growth factor receptor, known as OGFr. OGF-OGFr signalling has been studied in the regulation of cell proliferation.
Immune effects may depend on exposure and biological context. Direct OGF administration is not equivalent to low-dose naltrexone, which is a different medicine that blocks opioid receptors.
What Has Research Studied?
Work includes immune-cell experiments and animal models of autoimmune disease, including experimental autoimmune encephalomyelitis. Some literature also examines modulation of endogenous opioid pathways.
Human evidence for direct Met-Enkephalin administration continues to develop, alongside related research into low-dose naltrexone.
Safety and Medical Supervision
Direct peptide use for immune regulation is managed with appropriate clinical monitoring throughout treatment.
A physician should review opioid medicines, opioid antagonists and other treatment before any consideration of use. Product quality and local regulatory requirements also need assessment.
Frequently Asked Questions
Are Met-Enkephalin and OGF the same peptide?
OGF is another name for Met-Enkephalin in the context of growth-regulatory signalling. A physician can explain how the research applies.
Is OGF the same as low-dose naltrexone?
OGF is a peptide, while naltrexone is an opioid-receptor antagonist. A physician assesses their mechanisms and evidence separately.
Is it approved to treat autoimmune disease?
Direct Met-Enkephalin treatment is not an established approved approach for autoimmune disease. Specialist care remains essential.
Does the term low-dose establish safety?
A physician consultation reviews dosing, product quality and your current medicines.
References
Disclaimer
This information, including but not limited to texts, images, graphics, labels, ingredients, indications, potential benefits, and other materials contained on this website are for informational purposes only. No part of this website is intended to be a substitute for professional medical advice, treatment, or diagnosis. Always seek the advice of your physician or other professional healthcare provider, particularly before starting a new regimen for the first time.
Wondering Whether Met-Enkephalin Is Right for You?
Speak with our medical team about your health goals. We will help you understand which options are supported by evidence and appropriate for your situation.